Hypertension
Conditions
Interventions
Hypertensive patients using Olmesartan tablets 20mg take Olmesartan OD tablets 20mg.Intervention period : 1 day
Sponsors
Medical corporation Ishinkai Oda clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who are 20 years of age or older at the moment obtaining informed consent. 2) Patients who are already taking Olmesartan tablets 20mg from before more than two weeks of obtaining informed consent. 3) Patients who provided voluntary informed consent to participate in the study after receiving sufficient explanation.
Exclusion criteria
Exclusion criteria: 1) Patients who are taking dementia therapeutics. 2) Patients who are a history of hypersensitivity to Olmesartan tablet. 3) Diabetic patients who are taking aliskiren fumarate(Except for uncontrolled patients of blood pressure by doing other antihypertensive treatment.) 4) Patients who are pregnant or during lactation, or there is becoming the possibility of pregnant. 5) Patients who jugged unsuitable for this study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of sensory | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of safety | — |
Countries
Japan
Contacts
Public ContactKotaro Senuki
Sogo Rinsho Médéfi Co,Ltd. Business Promotion Department
Outcome results
None listed